Showing results (1-10 of 300) with videos related to

Sort By:
Pageof 30
Transplantation Proceedings|March 26, 2004
Impact of cyclosporine on the development of immunosuppressive therapyL Fritsche, D Dragun, H H Neumayer, et al.
Transplantation Proceedings|December 21, 2010
Why rejections are not biopsy proven: frequency and reasonsF Fleiner, P Glander, L Fritsche, et al.
European Journal of Medical Research|June 11, 2005
Pharmacokinetics of the immunosuppressant everolimus in maintenance renal transplant patientsK Budde, L Fritsche, J Waiser, et al.
Transplantation Proceedings|March 26, 2004
FTY720: early clinical experienceD Dragun, L Fritsche, T Boehler, et al.
Transplantation Proceedings|June 21, 2005
Differences in reporting of acute rejections between American and European publications of large immunosuppressive trials impair comparability of study resultsF Fleiner, K Budde, D Dragun, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|March 21, 1998
Mycophenolate mofetil pharmacokinetics in renal transplant recipients on peritoneal dialysisS Morgera, K Budde, D Lampe, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 6, 2004
Treating type 2 diabetes in renal insufficiency: the role of pioglitazoneL Fritsche, K Budde, P Glander, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 16, 2000
Age-matching in renal transplantationJ Waiser, M Schreiber, K Budde, et al.
Transplantation Proceedings|March 26, 2004
Enteric-coated mycophenolate sodium: safe conversion from mycophenolate mofetil in maintenance renal transplant recipientsK Budde, P Glander, F Diekmann, et al.
Transplantation Proceedings|April 26, 2005
Accurate prediction of kidney allograft outcome based on creatinine course in the first 6 months posttransplantL Fritsche, J Hoerstrup, K Budde, et al.
Pageof 30